Dr. Strickler is an Associate Professor of Medicine in the Division of Medical Oncology at Duke University, where he is Co-Leader of the Molecular Tumor Board and Associate Director of Clinical Research – GI Oncology. His clinic focuses on the treatment of gastrointestinal malignancies, with a particular emphasis on esophageal, gastric, pancreatic, and colorectal cancers. His research focuses on the design and execution of first-in-human and investigator-initiated clinical trials with correlative studies. He has a particular interest in non-invasive testing to identify and treat genomic drivers of treatment resistance. He has served on the ASCO Guidelines Committee for Locally Advanced Pancreatic Cancer, and he is co-Chair of the GI Steering Committee for the Academic and Community Cancer Research United (ACCRU) clinical trial consortium.